Center for Health Market Innovations (CHMI)

Programs

GlicOnLine

last updated Apr 17, 2013

Overview

Implementing organization: 
GlicOnLine
Legal Status: 
Year Launched: 
2004
Stage: 
Existing/expansion stage
Income Level of Target Population: 
20-60% (lower to lower-middle), 60-90% (middle to upper-middle), Top 10%

Funding

Primary Source of Funding: 
Donor

Technology

Technology Used: 
Computer › Apps/Software, Phones, Computer › Internet
Technology Purpose: 
Facilitating Patient Communications › Encouraging Patient Compliance, Extending Geographic Access, Improving Data Management › Data Organization/Analysis

Scale

Personnel Employed: 
<10
Number of Clients Served: 
2500 patients, 250 doctors
Summary: 

GlicOnLine is a software that runs on simple mobile phones and internet access devices and is controlled by physicians through the internet, that helps patients with Diabetes log blood sugar levels, count carbohydrates and calculate insulin doses.

Key program components: 

The company’s mission is to improve the quality of life of patients with diabetes. Dr Karla Mello, PhD, one of the partners of GlicOnLine, is a specialist in Endocrinology and Metabolism, and herself has diabetes. Her method aims to give diabetic patients a normal lifestyle. In 2002, Floro Dória, created a software that allowed for a quicker calculation of insulin dosage. The goal of this automation was to reduce barriers such as difficulty calculating proportions/insulin amounts and, therefore, increase the number of users who take advantage of this technology.

The information collected by the software is input into an electronic system that allows for simple calculation of insulin dosage. Clients have an online profile registered by their doctors, and can, at any given time, log into the system to determine their glycemic index, calculate nutrients intake, and choose food from a menu. The program calculates carbohydrates and fat content, and indicates back the amount of insulin that must be administered. The software allows doctors to monitor their patients online and change treatment parameters whenever necessary. Any prescription changes are automatically sent to the patients mobile phone.

GlicOnLine was incorporated in 2004, and received funding from the São Paulo Research Foundation (FAPESP - Fundação de Amparo à Pesquisa do Estado de São Paulo) to incubate the business, develop the software. Gliconline was finally launched in August of 2009. GlicOnLine has reached over 2500 patients as of early June 2011 and 250 doctors, who are now applying intensive insulin therapy safely.

Additional Information

PreviewAttachmentSize
Case_Study_Gliconline.pdf246.49 KB

Need help?

Using the CHMI Programs Database

  • Browse: Browse the database by applying one or more filters to narrow your search by characteristics. Click the "x" to remove any of the filters you've selected. Click "reset search" to remove all filters and start over.
  • Search: Search the database for a specific program by typing a name or keyword into the search box.
  • Add: If the program you're looking for is not in the CHMI database, submit the program to the CHMI pipeline by clicking here to add a program profile.
  • Update: If you notice incorrect or outdated information, or would like to help complete a profile for a CHMI pipeline program, request a change by clicking here, or at the top of the program profile.

Have a question? Check the FAQs first. Don’t see your question? Contact us.